Software outsmarts drug research

Now, a programme can bypass patented drug pathways and create synthetically-produced medicines

Rise of AMR could result in up to 10 million annual deaths by 2050: UN report

Some 24 million people could be pushed into extreme poverty due to rising AMR, the UNEP said

COVID-19 exposed dependence of world, India on China for active pharma ingredients

APIs are crucial for drugs and countries have put their eggs in a single basket; India has been discussing the issue for sometime

The end of meat and GMOs or the end of us: Part 1

The first in a three-part series series on effects of GMOs and the meat industry on our environment

The world needs pharmaceuticals from China and India to beat COVID-19

Chinese manufacturers make around 40% of all APIs used worldwide; China, India are the source of 75-80% of APIs imported to US

AMR driven by manufacturing our next big challenge

Antibiotics production is an important yet often forgotten driver of antimicrobial resistance; an alliance of pioneers has decided to pave the …

COVID-19 also brings focus back on pollution due to pharmaceuticals

No time for quick-fix measures. India needs stricter laws  

National List of Essential Medicines: 34 drugs enlisted in update after 7 years

The latest National List of Essential Medicines features 384 medicines, drops 26 old ones

COVID-19 and the big pharma mess

The pandemic has exposed a serious fault line in the global pharmaceutical supply chain, created by an industry that flourished by putting profit …

Ethical concerns eclipse world’s race to develop Ebola vaccine

World Health Organization and international community have been repeatedly slammed for delayed intervention

Missed calls from patients can help monitor TB treatment, says government

A special treatment kit which eases the procedure of treatment is being tested in two states

COVID-19 Challenge 2021: How does the world overcome vaccine shortage

The pharmaceuticals industry must come together to ensure all adults are vaccinated against the novel coronavirus; …

Antimicrobial resistance: The need to tackle access-excess problem

AMR, like every process, has its own drivers and determinants. The threat has evolved over time due to our acts of omission and commission

Ebola enters Mali, nearly 10,000 affected globally till now

With this, Mali has become the sixth West African country to be affected in the world's most deadliest outbreak of Ebola

Accident at Sainor unit in Vizag more proof of companies bypassing rules

Life-saving equipments were absent on-site though the company had approvals to show they were present

15 doctors went on foreign jaunt sponsored by pharma company, says Lok Sabha member

Doctors and pharma company deny charges

COVID-19: Centre brings package to boost bulk drugs

Indian pharma industry is critically dependent on imported raw material 

Marxists vs Paternalists vs Liberals: Where healthcare stands in India

How health as a right, investment and consumption regularly crops up in capitalist discourses 

Phase-II trials for new clot buster drug approved

Bio-therapeutic drug, Clot Specific Streptokinase, meant for patients who suffer heat attack, was developed using bacteria

Pristine Tasmania faces GM threat

Opium industry lobbies to lift moratorium on GM farming

Polluters get away by making ad hoc payment to farmers

No assessment yet of damage caused by industries to villages in Vadodara district

Supreme Court issues notice to Centre on HPV vaccines for cervical cancer

Gardasil and Cervarix were approved by drugs controller even though they are unproven and hazardous, alleges petition

The curious case of Ebola patents

The US government appears to have a cure and (almost) a vaccine for the deadly disease

Health activists ask Centre to stand firm on price control order for 50 life-saving drugs

Contrary to pharma industry claims, price control notifications for 50 cardiovascular and anti-diabetic drugs will impact retail market only …

US pharma strikes back

Upset by the Supreme Court’s endorsement of India’s patent law, the American drug industry is lobbying with Obama to tighten the …